MEPs exchange views on draft directive

摘要

Members of the European Parliament's Committee on Environment and Public Health (ENVI), meeting on 1 December, discussed the draft directive on prevention of the entry into the legal supply chain of counterfeit medicinal products (amendment of Directive 2001/83/EC). This first airing of views brought certain divergences to light.rn"There needs to be a definition of fal-sified medicinal products because we are in the process of legislating on some-thing that isn't defined," pointed out rapporteur Marisa Matias (GUE, Portugal). Although some MEPs recommend a very broad definition that encompasses both prescription and over-the-counter drugs, others see a need to make a clear distinction. Since there are still major differences between member states, it is preferable for safety measures to apply only to prescription medicines.